These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 23128765)

  • 1. Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.
    Goran MI; Alderete TL
    Nestle Nutr Inst Workshop Ser; 2012; 73():49-60; discussion p61-6. PubMed ID: 23128765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue inflammation and ectopic lipid accumulation.
    Suganami T; Tanaka M; Ogawa Y
    Endocr J; 2012; 59(10):849-57. PubMed ID: 22878669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of regulator of G protein signaling 5 exacerbates obesity, hepatic steatosis, inflammation and insulin resistance.
    Deng W; Wang X; Xiao J; Chen K; Zhou H; Shen D; Li H; Tang Q
    PLoS One; 2012; 7(1):e30256. PubMed ID: 22272317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin-1 regulates adiposity and metabolic dysfunction in diet-induced obesity enhancing adipose inflammation and stimulating adipocyte proliferation.
    Kong P; Gonzalez-Quesada C; Li N; Cavalera M; Lee DW; Frangogiannis NG
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E439-50. PubMed ID: 23757408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral fat and insulin resistance - what we know?
    Janochova K; Haluzik M; Buzga M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):19-27. PubMed ID: 30398218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.
    Lee MJ; Wu Y; Fried SK
    Mol Aspects Med; 2013 Feb; 34(1):1-11. PubMed ID: 23068073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?
    Blüher M
    Clin Sci (Lond); 2016 Sep; 130(18):1603-14. PubMed ID: 27503945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function.
    Goossens GH
    Obes Facts; 2017; 10(3):207-215. PubMed ID: 28564650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in nonalcoholic fatty liver disease.
    Bugianesi E; Moscatiello S; Ciaravella MF; Marchesini G
    Curr Pharm Des; 2010 Jun; 16(17):1941-51. PubMed ID: 20370677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine functions of adipose tissue.
    Waki H; Tontonoz P
    Annu Rev Pathol; 2007; 2():31-56. PubMed ID: 18039092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.
    Qureshi K; Abrams GA
    World J Gastroenterol; 2007 Jul; 13(26):3540-53. PubMed ID: 17659704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease.
    Strissel KJ; Denis GV; Nikolajczyk BS
    Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):330-8. PubMed ID: 25106001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
    Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
    Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S; Lulić D; Štimac D
    World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition, inflammation and thermogenesis in pathways to obesity and the metabolic syndrome: an overview.
    Dulloo AG; Montani JP
    Obes Rev; 2012 Dec; 13 Suppl 2():1-5. PubMed ID: 23107254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.